全文获取类型
收费全文 | 5587篇 |
免费 | 310篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 125篇 |
儿科学 | 325篇 |
妇产科学 | 125篇 |
基础医学 | 529篇 |
口腔科学 | 73篇 |
临床医学 | 295篇 |
内科学 | 1057篇 |
皮肤病学 | 110篇 |
神经病学 | 407篇 |
特种医学 | 178篇 |
外科学 | 888篇 |
综合类 | 275篇 |
预防医学 | 320篇 |
眼科学 | 248篇 |
药学 | 419篇 |
中国医学 | 18篇 |
肿瘤学 | 511篇 |
出版年
2022年 | 27篇 |
2021年 | 112篇 |
2020年 | 75篇 |
2019年 | 105篇 |
2018年 | 124篇 |
2017年 | 90篇 |
2016年 | 132篇 |
2015年 | 108篇 |
2014年 | 189篇 |
2013年 | 245篇 |
2012年 | 332篇 |
2011年 | 395篇 |
2010年 | 228篇 |
2009年 | 209篇 |
2008年 | 292篇 |
2007年 | 337篇 |
2006年 | 324篇 |
2005年 | 255篇 |
2004年 | 263篇 |
2003年 | 226篇 |
2002年 | 172篇 |
2001年 | 135篇 |
2000年 | 156篇 |
1999年 | 133篇 |
1998年 | 38篇 |
1997年 | 39篇 |
1996年 | 37篇 |
1995年 | 32篇 |
1993年 | 28篇 |
1992年 | 60篇 |
1991年 | 49篇 |
1990年 | 46篇 |
1989年 | 53篇 |
1988年 | 43篇 |
1987年 | 61篇 |
1986年 | 48篇 |
1985年 | 56篇 |
1984年 | 52篇 |
1983年 | 33篇 |
1979年 | 26篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1974年 | 34篇 |
1973年 | 49篇 |
1972年 | 42篇 |
1971年 | 37篇 |
1970年 | 30篇 |
1969年 | 35篇 |
1968年 | 36篇 |
1967年 | 25篇 |
排序方式: 共有5903条查询结果,搜索用时 16 毫秒
1.
2.
3.
Understanding why persons with human immunodeficiency virus (HIV) have accelerated atherosclerosis and its sequelae, including coronary artery disease (CAD) and myocardial infarction, is necessary to provide appropriate care to a large and aging population with HIV. In this review, we delineate the diverse pathophysiologies underlying HIV-associated CAD and discuss how these are implicated in the clinical manifestations of CAD among persons with HIV. Several factors contribute to HIV-associated CAD, with chronic inflammation and immune activation likely representing the primary drivers. Increased monocyte activation, inflammation, and hyperlipidemia present in chronic HIV infection also mirror the pathophysiology of plaque rupture. Furthermore, mechanisms central to plaque erosion, such as activation of toll-like receptor 2 and formation of neutrophil extracellular traps, are also abundant in HIV. In addition to inflammation and immune activation in general, persons with HIV have a higher prevalence than uninfected persons of traditional cardiovascular risk factors, including dyslipidemia, hypertension, insulin resistance, and tobacco use. Antiretroviral therapies, although clearly necessary for HIV treatment and survival, have had varied effects on CAD, but newer generation regimens have reduced cardiovascular toxicities. From a clinical standpoint, this mix of risk factors is implicated in earlier CAD among persons with HIV than uninfected persons; whether the distribution and underlying plaque content of CAD for persons with HIV differs considerably from uninfected persons has not been definitively studied. Furthermore, the role of cardiovascular risk estimators in HIV remains unclear, as does the role of traditional and emerging therapies; no trials of CAD therapies powered to detect clinical events have been completed among persons with HIV. 相似文献
4.
Prahlad V. Raninga Andy C. Lee Debottam Sinha Yu-Yin Shih Deepak Mittal Ashwini Makhale Amanda L. Bain Devathri Nanayakarra Kathryn F. Tonissen Murugan Kalimutho Kum Kum Khanna 《International journal of cancer. Journal international du cancer》2020,146(1):123-136
Triple-negative breast cancer (TNBCs) is a very aggressive and lethal form of breast cancer with no effective targeted therapy. Neoadjuvant chemotherapies and radiotherapy remains a mainstay of treatment with only 25–30% of TNBC patients responding. Thus, there is an unmet clinical need to develop novel therapeutic strategies for TNBCs. TNBC cells have increased intracellular oxidative stress and suppressed glutathione, a major antioxidant system, but still, are protected against higher oxidative stress. We screened a panel of antioxidant genes using the TCGA and METABRIC databases and found that expression of the thioredoxin pathway genes is significantly upregulated in TNBC patients compared to non-TNBC patients and is correlated with adverse survival outcomes. Treatment with auranofin (AF), an FDA-approved thioredoxin reductase inhibitor caused specific cell death and impaired the growth of TNBC cells grown as spheroids. Furthermore, AF treatment exerted a significant in vivo antitumor activity in multiple TNBC models including the syngeneic 4T1.2 model, MDA-MB-231 xenograft and patient-derived tumor xenograft by inhibiting thioredoxin redox activity. We, for the first time, showed that AF increased CD8+Ve T-cell tumor infiltration in vivo and upregulated immune checkpoint PD-L1 expression in an ERK1/2-MYC-dependent manner. Moreover, combination of AF with anti-PD-L1 antibody synergistically impaired the growth of 4T1.2 primary tumors. Our data provide a novel therapeutic strategy using AF in combination with anti-PD-L1 antibody that warrants further clinical investigation for TNBC patients. 相似文献
5.
6.
7.
8.
9.
10.